The Florida Senate

381.912  Cervical Cancer Elimination Task Force.--

(1)  Effective July 1, 2004, the Cervical Cancer Elimination Task Force is established for the purpose of recommending strategies and actions to reduce the costs and burdens of cervical cancer in Florida. The task force shall present interim reports to the Florida Public Health Foundation, Inc., the Florida Cancer Council, the Center for Universal Research to Eradicate Disease, the Governor, the President of the Senate, and the Speaker of the House of Representatives on January 1, 2006, and July 1, 2007, with a final report due on June 30, 2008. After submitting its final report on or before June 30, 2008, the task force is dissolved.

(2)  The task force shall:

(a)  Review statistical and qualitative data on the prevalence and burden of cervical cancer.

(b)  Receive and consider reports and testimony from individuals, county health departments, community-based organizations, and other public and private organizations statewide to learn more about their contributions to cervical cancer diagnosis, prevention, and treatment, as well as their ideas for improving the care of cervical cancer patients in this state.

(c)  Identify priority strategies and new technologies, including newly introduced vaccines, which are effective in preventing and controlling the risk of cervical cancer.

(d)  Provide recommendations to the Florida Public Health Foundation, Inc., on public awareness issues relating to cervical cancer, such as the causes, personal risk factors, value of prevention, available vaccines, early detection options, treatment costs, new technology, and education for health care practitioners.

(e)  Identify and examine existing programs, services, laws, and rules regarding the availability and coverage of treatment services for cervical cancer.

(f)  Develop and revise a comprehensive Florida Cervical Cancer Prevention Plan and present those recommendations to the Department of Health and the Florida Cancer Control and Research Advisory Council for incorporation into the Florida Cancer Plan.

(3)  The task force shall consist of:

(a)  The director of the Department of Health's Division of Disease Control or another person with expertise in epidemiology who shall serve as chair, appointed by the State Surgeon General.

(b)  A board-certified gynecologist licensed as a physician under chapter 458 or chapter 459 representing the Florida Obstetric and Gynecologic Society, appointed by the Governor.

(c)  A family physician licensed under chapter 458 or chapter 459 who provides gynecology services representing the Florida Academy of Family Physicians, appointed by the Governor.

(d)  An oncologist licensed as a physician under chapter 458 or chapter 459 representing the Florida Division of the American Cancer Society, appointed by the President of the Senate.

(e)  An advanced registered nurse practitioner who practices gynecology representing the Florida Nurses Association, appointed by the Speaker of the House of Representatives.

(f)  A member of the Legislative Women's Caucus, appointed by the President of the Senate.

(g)  A member of the Legislative Women's Caucus, appointed by the Speaker of the House of Representatives.

(h)  The chief executive officer of the H. Lee Moffitt Cancer Center and Research Institute or his or her designee.

(i)  The director of the University of Florida Shands Cancer Center or his or her designee.

(j)  The director of the University of Miami Sylvester Comprehensive Cancer Center or his or her designee.

(k)  The chief executive officer of the Mayo Clinic, Jacksonville, or his or her designee.

(4)  Members of the task force shall be appointed to 4-year terms without compensation, and each organization represented shall cover the expenses of its representative.

History.--s. 15, ch. 2004-2; s. 30, ch. 2008-6.